Quoin Pharmaceuticals (QNRX) Competitors $0.57 -0.08 (-12.03%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends QNRX vs. SSKN, LYRA, PYPD, QTI, PXDT, PETV, PAVM, STRR, ICU, and TTOOShould you be buying Quoin Pharmaceuticals stock or one of its competitors? The main competitors of Quoin Pharmaceuticals include STRATA Skin Sciences (SSKN), Lyra Therapeutics (LYRA), PolyPid (PYPD), QT Imaging (QTI), Pixie Dust Technologies (PXDT), PetVivo (PETV), PAVmed (PAVM), Star Equity (STRR), SeaStar Medical (ICU), and T2 Biosystems (TTOO). These companies are all part of the "medical equipment" industry. Quoin Pharmaceuticals vs. STRATA Skin Sciences Lyra Therapeutics PolyPid QT Imaging Pixie Dust Technologies PetVivo PAVmed Star Equity SeaStar Medical T2 Biosystems STRATA Skin Sciences (NASDAQ:SSKN) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, community ranking, dividends, analyst recommendations, profitability and media sentiment. Do insiders and institutionals hold more shares of SSKN or QNRX? 32.4% of STRATA Skin Sciences shares are owned by institutional investors. Comparatively, 8.6% of Quoin Pharmaceuticals shares are owned by institutional investors. 39.0% of STRATA Skin Sciences shares are owned by insiders. Comparatively, 3.7% of Quoin Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts recommend SSKN or QNRX? Quoin Pharmaceuticals has a consensus target price of $4.00, indicating a potential upside of 602.99%. Given Quoin Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Quoin Pharmaceuticals is more favorable than STRATA Skin Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STRATA Skin Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Quoin Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in SSKN or QNRX? STRATA Skin Sciences received 218 more outperform votes than Quoin Pharmaceuticals when rated by MarketBeat users. Likewise, 63.90% of users gave STRATA Skin Sciences an outperform vote while only 55.56% of users gave Quoin Pharmaceuticals an outperform vote. CompanyUnderperformOutperformSTRATA Skin SciencesOutperform Votes22363.90% Underperform Votes12636.10% Quoin PharmaceuticalsOutperform Votes555.56% Underperform Votes444.44% Which has more volatility and risk, SSKN or QNRX? STRATA Skin Sciences has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Quoin Pharmaceuticals has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500. Which has stronger earnings and valuation, SSKN or QNRX? Quoin Pharmaceuticals has lower revenue, but higher earnings than STRATA Skin Sciences. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Quoin Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTRATA Skin Sciences$32.68M0.37-$10.83M-$2.66-1.09Quoin PharmaceuticalsN/AN/A-$8.69M-$4.05-0.14 Does the media favor SSKN or QNRX? In the previous week, Quoin Pharmaceuticals had 6 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 6 mentions for Quoin Pharmaceuticals and 0 mentions for STRATA Skin Sciences. Quoin Pharmaceuticals' average media sentiment score of 0.27 beat STRATA Skin Sciences' score of 0.00 indicating that Quoin Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment STRATA Skin Sciences Neutral Quoin Pharmaceuticals Neutral Is SSKN or QNRX more profitable? Quoin Pharmaceuticals has a net margin of 0.00% compared to STRATA Skin Sciences' net margin of -28.72%. STRATA Skin Sciences' return on equity of -69.33% beat Quoin Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets STRATA Skin Sciences-28.72% -69.33% -17.55% Quoin Pharmaceuticals N/A -125.60%-64.77% SummaryQuoin Pharmaceuticals beats STRATA Skin Sciences on 9 of the 17 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get Quoin Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for QNRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart QNRX vs. The Competition Export to ExcelMetricQuoin PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.87M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-0.1410.5990.0517.20Price / SalesN/A196.061,117.09117.04Price / CashN/A57.1643.1037.85Price / Book0.105.094.784.78Net Income-$8.69M$151.83M$120.31M$225.60M7 Day Performance-14.05%-2.14%-1.92%-1.23%1 Month Performance-2.74%-4.56%13.65%0.46%1 Year Performance-87.27%8.87%28.34%15.24% Quoin Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)QNRXQuoin Pharmaceuticals2.9085 of 5 stars$0.57-12.0%$4.00+603.0%-86.3%$2.87MN/A-0.144News CoverageGap DownSSKNSTRATA Skin Sciences1.0262 of 5 stars$2.99-0.3%N/A-51.5%$12.47M$32.68M-1.11120LYRALyra Therapeutics2.4053 of 5 stars$0.19+3.1%$4.50+2,291.1%-96.1%$12.32M$1.47M-0.1250Gap DownPYPDPolyPid2.3344 of 5 stars$2.37-9.2%$12.00+406.3%-17.6%$11.38MN/A-0.3080Analyst RevisionHigh Trading VolumeQTIQT ImagingN/A$0.47-6.8%N/AN/A$10.17M$4.00M0.00N/APXDTPixie Dust Technologies1.8534 of 5 stars$0.58+9.2%$5.21+798.4%N/A$8.62M$993.02M0.0078High Trading VolumePETVPetVivoN/A$0.41-0.9%N/A-61.2%$8.36M$970,000.00-0.8520News CoveragePAVMPAVmed3.7482 of 5 stars$0.75-2.6%$19.00+2,450.3%-84.8%$8.25M$2.45M-0.1890News CoverageSTRRStar Equity1.0247 of 5 stars$2.53-3.8%N/A-57.9%$8.14M$50.38M-1.02171News CoverageGap UpHigh Trading VolumeICUSeaStar Medical0.1027 of 5 stars$1.82-8.5%N/A-81.6%$8.12M$68,000.00-0.172TTOOT2 Biosystems2.7789 of 5 stars$0.37+1.4%$5.00+1,250.6%-92.7%$7.79M$7.19M0.00180Analyst ForecastGap UpHigh Trading Volume Related Companies and Tools Related Companies SSKN Competitors LYRA Competitors PYPD Competitors QTI Competitors PXDT Competitors PETV Competitors PAVM Competitors STRR Competitors ICU Competitors TTOO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:QNRX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quoin Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
